Literature DB >> 1732438

The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT.

B L Holman1, K A Johnson, B Gerada, P A Carvalho, A Satlin.   

Abstract

Alzheimer's disease produces regional abnormalities in brain blood flow and metabolism that may result in recognizable scintigraphic patterns. We determined the predictive value of 99mTc-HMPAO SPECT for the presence of Alzheimer's disease based on a prospective study of 132 consecutive patients coming to our nuclear medicine clinical unit for evaluation of their memory loss or cognitive abnormalities. During clinical follow-up averaging 10.1 mo, a final diagnosis was established in 113 patients, 52 of which had Alzheimer's disease. The probability of Alzheimer's disease was determined for seven scintigraphic patterns. The probability was 19% that patients with memory loss and normal perfusion had Alzheimer's disease. For abnormal perfusion patterns, the probability of Alzheimer's disease was 82% with bilateral temporoparietal defects, 77% with bilateral temporoparietal defects with additional defects, 57% with unilateral temporoparietal defects, 43% with frontal defects only, 18% with other large defects and 0% with multiple small cortical defects. We conclude that for 99mTc-HMPAO SPECT the predictive value of bilateral temporoparietal defects for Alzheimer's disease is high, while the perfusion patterns of unilateral temporoparietal perfusion defects and frontal defects only, which occur in 20% of patients with Alzheimer's disease, are not predictive of that disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1732438

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  37 in total

1.  Magnetization transfer measurements of the hippocampus in patients with Alzheimer's disease, vascular dementia, and other types of dementia.

Authors:  H Hanyu; T Asano; T Iwamoto; M Takasaki; H Shindo; K Abe
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

2.  For: Can ROI methodology/normalised tissue activities be used instead of absolute blood flow measurements in the brain?

Authors:  Durval C Costa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-07       Impact factor: 9.236

3.  Association between medial temporal lobe atrophy on CT and parietotemporal uptake decrease on SPECT in Alzheimer's disease.

Authors:  I Lavenu; F Pasquier; F Lebert; B Jacob; H Petit
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

4.  Relationships between cognitive impairment on ADAS-cog and regional cerebral blood flow using SPECT in late-onset Alzheimer's disease.

Authors:  Michio Takahashi; Yasunori Oda; Toshiyuki Okubo; Yukihiko Shirayama
Journal:  J Neural Transm (Vienna)       Date:  2017-05-16       Impact factor: 3.575

5.  Optimized data preprocessing for multivariate analysis applied to 99mTc-ECD SPECT data sets of Alzheimer's patients and asymptomatic controls.

Authors:  Dorit Merhof; Pawel J Markiewicz; Günther Platsch; Jerome Declerck; Markus Weih; Johannes Kornhuber; Torsten Kuwert; Julian C Matthews; Karl Herholz
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-14       Impact factor: 6.200

6.  Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load.

Authors:  A Bozzao; R Floris; M E Baviera; A Apruzzese; G Simonetti
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

7.  Quantification of functional deficit in Alzheimer's disease using a computer-assisted mapping program for 99mTc-HMPAO SPECT.

Authors:  H Karbe; A Kertesz; J Davis; B J Kemp; F S Prato; R L Nicholson
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

Review 8.  NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.

Authors:  Alireza Minagar; Deborah Commins; J Steven Alexander; Romy Hoque; Francesco Chiappelli; Elyse J Singer; Behrooz Nikbin; Paul Shapshak
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

9.  Heterogeneity of cerebral blood flow in Alzheimer disease and vascular dementia.

Authors:  Takuya Yoshikawa; Kenya Murase; Naohiko Oku; Masao Imaizumi; Masashi Takasawa; Piao Rishu; Yasuyuki Kimura; Yoshitaka Ikejiri; Kazuo Kitagawa; Masatsugu Hori; Jun Hatazawa
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

10.  A new approach for improving diagnostic accuracy in Alzheimer's disease and frontal lobe dementia utilising the intrinsic properties of the SPET dataset.

Authors:  Marco Pagani; Vassili A Kovalev; Roger Lundqvist; Hans Jacobsson; Stig A Larsson; Lennart Thurfjell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-29       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.